Pemazyre® (pemigatinib)
for Cholangiocarcinoma – Bile Duct Cancer

Pemazyre (pemigatinib) is a kinase inhibitor used to treat adults with bile duct cancer (cholangiocarcinoma) that is metastatic or cannot be removed by surgery. It is prescribed after prior treatment and for cancers with an abnormal FGFR2 gene. Pemazyre works by blocking protein kinases that promote cancer cell growth, helping to slow or stop tumor progression.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Cholangiocarcinoma - Bile Duct Cancer